ICH-GCP E6(R2)

Master this essential documentation concept

Quick Definition

International Council for Harmonisation Good Clinical Practice guidelines that establish ethical and scientific quality standards for designing, conducting, and reporting clinical trials.

How ICH-GCP E6(R2) Works

graph TD A[ICH-GCP E6 R2 Standards] --> B[Documentation Requirements] A --> C[Quality Management] A --> D[Compliance Framework] B --> B1[Protocol & Amendments] B --> B2[Informed Consent Forms] B --> B3[Case Report Forms] B --> B4[Safety Reports] C --> C1[Risk Assessment] C --> C2[Quality Oversight] C --> C3[Audit Trails] D --> D1[Regulatory Submissions] D --> D2[Data Integrity] D --> D3[Subject Protection] B1 --> E[Documentation Team] B2 --> E B3 --> E B4 --> E C1 --> E C2 --> E C3 --> E E --> F[Compliant Trial Records] F --> G[Regulatory Approval] style A fill:#4A90E2 style E fill:#7ED321 style G fill:#50E3C2

Understanding ICH-GCP E6(R2)

ICH-GCP E6(R2) represents the second revision of the foundational guidelines that govern clinical trial conduct globally. Released in 2016, this updated version incorporates modern practices, technological advances, and lessons learned from decades of clinical research. For documentation professionals, E6(R2) establishes mandatory requirements for creating, maintaining, and managing comprehensive trial documentation that ensures regulatory compliance and data integrity.

Key Features

  • Comprehensive documentation requirements for all trial phases
  • Risk-based monitoring and quality oversight approaches
  • Electronic records and signatures validation standards
  • Subject safety and rights protection protocols
  • Clear accountability and traceability requirements
  • Enhanced guidance on data integrity and audit trails
  • Flexible implementation allowing risk-proportionate approaches

Benefits for Documentation Teams

  • Provides clear, standardized documentation frameworks reducing ambiguity
  • Enables consistent quality standards across multiple trial sites
  • Supports regulatory acceptance and accelerates approval timelines
  • Establishes audit-ready documentation practices from inception
  • Protects organizations through comprehensive compliance documentation
  • Facilitates international trial coordination with harmonized standards

Common Misconceptions

  • E6(R2) requires excessive paperwork—it actually emphasizes proportionate, risk-based documentation
  • Only applies to pharmaceutical companies—applies to all clinical trial sponsors and investigators
  • Eliminates flexibility—includes risk-based approaches allowing tailored implementation
  • Outdated for digital trials—specifically updated to accommodate electronic systems and innovative technologies

Real-World Documentation Use Cases

Protocol Documentation and Version Control

Problem

Clinical trial protocols undergo multiple revisions during development and execution. Documentation teams struggle to maintain version control, track amendment rationales, and ensure all stakeholders access current versions while preserving historical records for audit purposes.

Solution

Implement ICH-GCP E6(R2) documentation standards requiring structured protocol documentation with clear version numbering, amendment tracking, approval chains, and rationale documentation for each change.

Implementation

['Establish protocol template aligned with E6(R2) requirements including sections for objectives, methodology, safety parameters, and statistical analysis', 'Create amendment tracking system documenting reason for change, approval dates, and effective dates', 'Implement version control software with role-based access ensuring only authorized personnel modify protocols', 'Maintain master file containing protocol, all amendments, and approval documentation', 'Document stakeholder review and approval signatures with timestamps', 'Archive previous versions with clear identification as superseded']

Expected Outcome

Regulatory inspectors can trace protocol evolution, understand rationale for changes, and verify compliance with planned conduct. Documentation teams reduce amendment-related delays and maintain audit-ready records throughout trial lifecycle.

Informed Consent Form Compliance and Translation Management

Problem

Multi-site, international clinical trials require ICFs in multiple languages. Documentation teams must ensure translations maintain scientific accuracy, cultural appropriateness, and regulatory compliance while tracking versions across different regions.

Solution

Apply E6(R2) ICF requirements through structured documentation processes that standardize consent content, manage translations systematically, and document all review and approval stages.

Implementation

['Develop master ICF template meeting E6(R2) content requirements including study objectives, procedures, risks, benefits, and subject rights', 'Establish translation protocol requiring certified translators and back-translation verification', 'Create approval workflow documenting institutional review board, ethics committee, and regulatory authority reviews', 'Maintain documentation of translation decisions and cultural adaptations with scientific justification', 'Track version numbers by country/language with effective dates', 'Document subject comprehension assessments and feedback incorporation']

Expected Outcome

Regulatory authorities receive complete documentation demonstrating informed consent validity across all trial populations. Documentation teams ensure subject protection through transparent, comprehensible consent processes and maintain compliance with international regulations.

Case Report Form Design and Data Integrity Management

Problem

CRFs collect critical trial data requiring accuracy and traceability. Documentation teams must design forms minimizing data entry errors, maintain audit trails for corrections, and ensure electronic systems meet E6(R2) data integrity standards.

Solution

Implement E6(R2) data integrity principles through CRF design standards, electronic signature protocols, and comprehensive audit trail documentation.

Implementation

['Design CRFs with clear instructions, logical flow, and data validation rules minimizing transcription errors', 'Specify required fields, acceptable data ranges, and data format requirements', 'Document CRF development including rationale for data elements and validation logic', 'Implement electronic CRF systems with automated audit trails capturing all data entries, modifications, and deletions', 'Establish electronic signature procedures with access controls and timestamp documentation', 'Create data correction procedures documenting original entries, corrections, justifications, and approver information', 'Maintain CRF version control with training documentation for all users']

Expected Outcome

Trial data achieves regulatory-grade integrity with complete traceability. Documentation teams reduce data quality issues, accelerate regulatory review, and provide inspectors with transparent data management documentation.

Adverse Event Reporting and Safety Documentation

Problem

Clinical trials require rapid, accurate safety reporting to regulatory authorities and ethics committees. Documentation teams must ensure safety reports meet E6(R2) timeliness requirements while maintaining detailed documentation of assessment, causality determination, and reporting decisions.

Solution

Establish E6(R2)-compliant safety documentation procedures with clear timelines, assessment criteria, and reporting documentation.

Implementation

['Create safety reporting procedures defining serious adverse event definitions and reporting timelines', 'Develop assessment forms documenting event details, severity, causality assessment, and expectedness determination', 'Establish expedited reporting procedures for serious adverse events with documented timelines', 'Create central safety database with audit trails tracking all safety information', 'Document safety committee reviews including meeting minutes, causality assessments, and recommendations', 'Maintain regulatory submission documentation including reports submitted, dates, and responses received', 'Implement safety signal monitoring procedures with documented assessment and follow-up actions']

Expected Outcome

Safety reporting meets regulatory timelines and demonstrates systematic safety oversight. Documentation teams protect subject welfare through transparent safety management and provide regulators with comprehensive safety documentation supporting trial integrity.

Best Practices

âś“ Implement Risk-Based Documentation Approaches

E6(R2) emphasizes proportionate documentation aligned with trial complexity and risk. Rather than applying identical documentation rigor to all trials, assess risk factors including trial phase, subject population vulnerability, investigational product novelty, and trial complexity. Allocate documentation resources proportionally, ensuring comprehensive documentation for high-risk elements while streamlining processes for lower-risk activities.

âś“ Do: Conduct risk assessments before trial initiation identifying documentation-intensive areas; implement quality oversight proportional to identified risks; document risk assessment rationale; adjust documentation requirements based on ongoing monitoring data
âś— Don't: Apply uniform documentation standards regardless of trial risk profile; over-document low-risk activities consuming unnecessary resources; under-document high-risk elements to reduce workload; fail to document risk assessment methodology

âś“ Establish Comprehensive Electronic Records Management Systems

E6(R2) explicitly addresses electronic records and signatures, recognizing that modern trials increasingly utilize digital systems. Implement electronic systems meeting validation requirements including audit trail functionality, access controls, and data integrity protections. Ensure systems maintain complete records of all data creation, modification, and review activities with timestamp and user identification.

âś“ Do: Validate electronic systems before trial use documenting functionality and security features; implement role-based access controls; maintain complete audit trails; establish backup and disaster recovery procedures; provide user training on system requirements
âś— Don't: Implement unvalidated systems assuming compliance; disable audit trail functionality for convenience; use shared login credentials; fail to maintain system documentation; neglect regular security updates

âś“ Create Clear Accountability and Responsibility Documentation

E6(R2) emphasizes documented accountability throughout trial conduct. Define roles, responsibilities, and authority levels for all personnel involved in documentation processes. Document decision-making authority, approval requirements, and escalation procedures. Maintain records demonstrating that qualified personnel performed required functions with appropriate oversight and verification.

âś“ Do: Document organizational structure and reporting relationships; define specific responsibilities for key trial functions; establish approval authorities with documented justification; maintain records of training and qualification verification; document delegation of responsibilities with evidence of competency
âś— Don't: Leave responsibilities ambiguous or undocumented; allow unqualified personnel to perform critical functions; fail to document approval authorities; neglect training documentation; implement processes without clear ownership

âś“ Maintain Audit-Ready Documentation from Trial Initiation

Rather than preparing documentation retrospectively for regulatory inspection, implement processes ensuring documentation continuously meets audit standards. Organize records systematically, maintain clear file structures, implement regular quality checks, and address deficiencies promptly. This approach reduces inspection findings, accelerates regulatory review, and demonstrates commitment to compliance.

âś“ Do: Organize documentation using standardized filing systems; conduct regular documentation quality audits; maintain comprehensive indices and cross-references; promptly correct identified deficiencies; preserve original records and approval documentation; implement document retention procedures meeting regulatory requirements
âś— Don't: Defer documentation organization until inspection notice; create documentation solely for inspection purposes; discard supporting records after regulatory approval; implement inconsistent filing practices across sites; fail to address quality audit findings

âś“ Document Quality Oversight and Continuous Improvement Activities

E6(R2) requires documented quality management throughout trial conduct. Establish processes for monitoring documentation quality, identifying deficiencies, and implementing corrective actions. Document all quality oversight activities including audits, inspections, findings, and corrective action implementation. This demonstrates systematic commitment to quality and provides evidence of continuous improvement.

âś“ Do: Conduct regular documentation quality audits with documented findings; implement documented corrective action procedures; track corrective action implementation and effectiveness; maintain records of quality oversight activities; involve relevant personnel in continuous improvement; document lessons learned and process improvements
âś— Don't: Conduct audits without documenting findings; identify deficiencies without corrective action; fail to verify corrective action effectiveness; neglect to document quality oversight activities; implement improvements without documenting rationale; ignore audit findings

How Docsie Helps with ICH-GCP E6(R2)

Build Better Documentation with Docsie

Join thousands of teams creating outstanding documentation

Book a Demo